Glen Weiss has been appointed chief medical officer of Circulogene. Prior to his appointment, he was director of clinical research and trials at the Cancer Treatment Centers of America. He holds a medical degree from the Sackler School of Medicine in Tel Aviv and an MBA from the W.P. Carey School of Business at Arizona State University.
Cancer Research UK and the University of Cambridge recently announced Greg Hannon as the new director of the Cancer Research UK Cambridge Institute. Hannon joined the Cancer Research UK Cambridge Institute in 2014 as a senior group leader. Prior to that he spent more than 20 years at Cold Spring Harbor Laboratory where he was a Howard Hughes Medical Institute Investigator and chaired the cancer genetics program as part of the Lab's National Cancer Institute-designated cancer center.
Zymo Research recently appointed Jonathan Eisen to its scientific advisory board. Eisen currently works at the University of California, Davis, where he holds appointments in the Department of Evolution and Ecology in the College of Biological Sciences and in the Department of Medical Microbiology and Immunology in the School of Medicine. He received his PhD in biology in 1998 from Stanford University, where he worked on the evolution of DNA repair. He has published more than 300 scientific articles and is a member of the American Academy of Microbiology.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.